Roles of polymorphic COMT, tea polyphenols and proteasome in cancer prevention
Roles of polymorphic COMT, tea polyphenols and proteasome in cancer prevention
批准号:
7355585
负责人:
QING PING DOU
金额:
$23.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-12 至 2011-02-28
关键词:
Acquired Immunodeficiency SyndromeAddressAffinityAllelesAnimalsAntineoplastic AgentsApoptosisApoptoticBeveragesBindingBiologicalBiological AvailabilityBiological ProcessBoronic AcidsBreast Cancer CellCaspaseCatechol O-MethyltransferaseCatecholsCaucasiansCaucasoid RaceCell CycleCell DeathCell ExtractsCellsCessation of lifeClinicalComputer SimulationConsumptionCultured CellsDataDiseaseDoctor of PhilosophyEndopeptidasesEpidemiologic StudiesEpigallocatechin GallateEstersFutureGeneral PopulationGenotypeGlycolGreen teaHomologous GeneHumanHydrolysisInterventionMalignant NeoplasmsMammary NeoplasmsMediatingMetabolic BiotransformationMethylationMethyltransferase GeneModelingMolecularMolecular TargetMultiple MyelomaMutateNormal CellNude MiceNumbersObject AttachmentOncogenesOrganismPathway interactionsPatientsPeptide HydrolasesPeptidesPhase I/II TrialPhase III Clinical TrialsPopulationProcessPropertyProteasome InhibitorProteinsRangeReactionReportingResearchResearch PersonnelResistanceRiskRoleSeriesStimulusStructureStudy SectionTeaTestingTrypsinUbiquitinUnited StatesUnited States Food and Drug AdministrationWomanXenograft procedureanalogbaseboronic acidcancer cellcancer preventioncell suicidechymotrypsindesigngallocatecholgenetic regulatory proteinin vivoinhibitor/antagonistmalignant breast neoplasmmulticatalytic endopeptidase complexneoplastic cellnovelpolyphenolprevention clinical trialprogramstumor xenograft
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Research has supported proteasome inhibitors as potential novel anticancer drugs and green tea
polyphenols (GTPs) as a cancer-preventative agent. We have reported that GTPs, e.g. (-)-epigallocatechin-
3-gallate or EGCG, are potent and specific inhibitors of proteasomal chymotrypsin-like activity (mediated by
b5 subunit). Methylation of GTPs, a major biotransformation reaction limiting their cancer-preventative
activities in vivo, is mediated by human polymorphic catechol-O-methyltransferase (COMT). The point-
mutated COMT, found in -25% of US population, has 3-4-fold decreased enzymatic activity (COMT-LL). It
was reported that women tea-drinkers with at least one low activity COMT allele (but not COMT-HH) showed
a significantly reduced risk of breast cancer compared with non-tea drinkers, suggesting less protection by
methylated polyphenols. To study the responsible mechanism, we hypothesize that O-methylation of GTPs
by COMT in breast cancer cells decreases their proteasome-inhibitory and consequently biological activities.
This hypothesis is supported by our preliminary results. To further this study, we propose 5 specific Aims. (1)
Synthesize O-methylated GTP analogs (by replacing -OH with -OCH3), the deoxy compounds (without the
catechol diol), and polyphenol homologs (replacing -OH with -CH2OH) and determine their binding affinity
to the proteasomal b5 subunit by employing computational modeling. (2) Evaluate potencies of these
synthetic compounds to inhibit the proteasome activity using purified 20S proteasome, breast cancer cell
extracts, and intact breast cancer cells. (3) Evaluate the apoptosis-inducing potencies of these synthetic
compounds in human breast cancer cells. (4) Determine the effects of over- and under-expression of COMT
gene in cultured human breast cancer cells on methylation of GTPs and their proteasome-inhibitory and
apoptosis-inducing activities. (5) Determine whether methylation of GTPs is a mechanism to inactivate their
biological functions in vivo using nude mice bearing human breast tumor xenografts. These studies should
help develop a fundamental understanding about how the polymorphic COMT regulates the biological
functions of GTPs in breast cancer cells and the impact of GTP methylation by COMT on the cancer-
preventative effects of tea consumption as well as generate important information for designing future cancer
prevention clinical trials using GTPs alone or in combination with a COMT inhibitor.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
(PQA1) Regulation of Metformin Response by Breast Cancer Associated Gene 2 (BCA2)
-
批准号:8848363
-
项目类别:
-
资助金额:$16.53万
-
财政年份:2014
-
负责人:QING PING DOU
-
依托单位:
(PQA1) Regulation of Metformin Response by Breast Cancer Associated Gene 2 (BCA2)
-
批准号:8685444
-
项目类别:
-
资助金额:$19.84万
-
财政年份:2014
-
负责人:QING PING DOU
-
依托单位:
Roles of polymorphic COMT, tea polyphenols and proteasome in cancer prevention
-
批准号:7909204
-
项目类别:
-
资助金额:$26.33万
-
财政年份:2009
-
负责人:QING PING DOU
-
依托单位:
The BCA2 Ubiquitin E3 Ligase as a Target in Breast Cancer
-
批准号:7848072
-
项目类别:
-
资助金额:$23.72万
-
财政年份:2007
-
负责人:QING PING DOU
-
依托单位:
The BCA2 Ubiquitin E3 Ligase as a Target in Breast Cancer
-
批准号:8072551
-
项目类别:
-
资助金额:$23.01万
-
财政年份:2007
-
负责人:QING PING DOU
-
依托单位:
Roles of polymorphic COMT, tea polyphenols and proteasome in cancer prevention
-
批准号:7578945
-
项目类别:
-
资助金额:$23.35万
-
财政年份:2006
-
负责人:QING PING DOU
-
依托单位:
Roles of polymorphic COMT, tea polyphenols and proteasome in cancer prevention
-
批准号:7070198
-
项目类别:
-
资助金额:$25.31万
-
财政年份:2006
-
负责人:QING PING DOU
-
依托单位:
Roles of polymorphic COMT, tea polyphenols and proteasome in cancer prevention
-
批准号:7774417
-
项目类别:
-
资助金额:$23.35万
-
财政年份:2006
-
负责人:QING PING DOU
-
依托单位:
Roles of polymorphic COMT, tea polyphenols and proteasome in cancer prevention
-
批准号:7221981
-
项目类别:
-
资助金额:$23.35万
-
财政年份:2006
-
负责人:QING PING DOU
-
依托单位:
The Proteasome as Molecular Target of Grape Polyphenols
-
批准号:6952307
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2004
-
负责人:QING PING DOU
-
依托单位:
The Proteasome as Molecular Target of Grape Polyphenols
-
批准号:6877457
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2004
-
负责人:QING PING DOU
-
依托单位:
TEA TARGETING PROTEASOME--A ROLE IN CANCER PREVENTION
-
批准号:6334635
-
项目类别:
-
资助金额:$7.25万
-
财政年份:2001
-
负责人:QING PING DOU
-
依托单位:
TEA TARGETING PROTEASOME--A ROLE IN CANCER PREVENTION
-
批准号:6515078
-
项目类别:
-
资助金额:$7.25万
-
财政年份:2001
-
负责人:QING PING DOU
-
依托单位:
FUNCTIONS OF RB PROTEASE(S) IN APOPTOSIS
-
批准号:2376199
-
项目类别:
-
资助金额:$10.15万
-
财政年份:1996
-
负责人:QING PING DOU
-
依托单位:
FUNCTIONS OF RB PROTEASE(S) IN APOPTOSIS
-
批准号:2882066
-
项目类别:
-
资助金额:$10.56万
-
财政年份:1996
-
负责人:QING PING DOU
-
依托单位:
FUNCTIONS OF RB PROTEASE(S) IN APOPTOSIS
-
批准号:6163772
-
项目类别:
-
资助金额:$10.98万
-
财政年份:1996
-
负责人:QING PING DOU
-
依托单位:
FUNCTIONS OF RB PROTEASE(S) IN APOPTOSIS
-
批准号:2055261
-
项目类别:
-
资助金额:$9.75万
-
财政年份:1996
-
负责人:QING PING DOU
-
依托单位:
FUNCTIONS OF RB PROTEASE(S) IN APOPTOSIS
-
批准号:2776771
-
项目类别:
-
资助金额:$5.63万
-
财政年份:1996
-
负责人:QING PING DOU
-
依托单位:
FUNCTIONS OF PPRB-SPECIFIC PROTEASES IN APPOTOSIS
-
批准号:2055260
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1995
-
负责人:QING PING DOU
-
依托单位:
海外基金